Investors can access the live webcast through the company’s portal, though participation in the Q&A session requires prior registration. Those who sign up will receive a unique dial-in number and PIN to facilitate direct interaction during the call. Additionally, a slide presentation will be posted to the investor relations section of the website when trading begins that morning, with a recording of the event remaining accessible for 90 days.
West Pharmaceutical Services Sets July 23 Date for Q2 Results
West Pharmaceutical Services will release its second-quarter 2026 financial results before the opening bell on Thursday, July 23, 2026. The Exton-based company, a major player in injectable drug administration, intends to host a live conference call at 8:00 a.m. Eastern Time to detail its quarterly performance and business outlook.
West currently supports global pharmaceutical development from its Exton headquarters, overseeing a network that spans 50 sites and 26 manufacturing facilities. The company, which maintains a position on the S&P 500, reported $3.07 billion in net sales for the 2025 fiscal year and delivers over 41 billion components annually to its partners.
Comments (0)
No comments yet. Be the first!